البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
RIVASTIGMINE
DEXCEL LTD, ISRAEL
N06DA03
PATCHES
RIVASTIGMINE 13.8 MG
TRANSDERMAL
Required
LUYE PHARMA AG, GERMANY
RIVASTIGMINE
Treatment of mild to moderate dementia of the Alzheimer's type.
2022-06-30
PATIENT PACKAGE INSERT ACCORDING TO PHARMACISTS' REGULATIONS (PREPARATIONS) – 1986 This medicine can be sold with a physician’s prescription only RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H A PATCH FOR USE ON THE SKIN (TRANSDERMAL PATCH) EACH PATCH CONTAINS: RIVASTIGMINE PATCH DEXCEL 4.6 MG/24 H: a 4.6 cm 2 transdermal patch containing 6.9 mg rivastigmine. The release rate of the medicine is: 4.6 mg in 24 hours. RIVASTIGMINE PATCH DEXCEL 9.5 MG/24 H: a 9.2 cm 2 transdermal patch containing 13.8 mg rivastigmine. The release rate of the medicine is: 9.5 mg in 24 hours. Inactive ingredients and allergens in the medicine – see section 6 "Additional information". READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any further questions, ask the doctor or pharmacist. This medicine has been prescribed to treat your illness. Do not pass it on to others. It may harm them, even if you think that their illness is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? For the treatment of mild to moderate Alzheimer's dementia (memory problems). THERAPEUTIC GROUP: Cholinesterase enzyme inhibitors (anticholinesterases). Rivastigmine belongs to a group of substances called cholinesterase inhibitors. In patients with Alzheimer’s dementia, certain nerve cells in the brain die, and cause low levels of the neurotransmitter acetylcholine (a substance that allows nerve cells to communicate with each other). Rivastigmine works by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase. By blocking these enzymes, RIVASTIGMINE PATCH DEXCEL allows the acetylcholine levels in the brain to be increased, and helps to reduce the symptoms of Alzheimer’s disease. RIVASTIGMINE PATCH DEXCEL is intended for the treatment of adult patients with mild and moderate dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behavior. 2. BEFORE USING THE MEDI اقرأ الوثيقة كاملة